DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Repurchase 
QIAGEN N.V.: Release of a capital market information 
 
2020-12-22 / 10:31 
Dissemination of a Post-admission Duties announcement transmitted by DGAP - 
a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
*Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 
596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated 
EU Regulation 2016/1052 / Share Repurchase - Final Reporting* 
 
With disclosure dated November 11, 2020, QIAGEN N.V. announced pursuant to 
Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 
Section (1) of the Delegated EU Regulation no 2016/1052 the immediate 
beginning of a fourth tranche of up to USD 100 million under the share 
repurchase program originally announced on May 6, 2019. 
 
The number of shares which have been bought back on the electronic trading 
platform of the Frankfurt Stock Exchange (XETRA) within the framework of 
such tranche of the share repurchase program in the time period from 
December 14, 2020 until and including December 17, 2020 amounts to 400 
shares. 
 
Shares were bought back as follows: 
 
    *Date*       *Number of    *Average Price  *Purchased Volume 
                   Shares          (EUR)*           (EUR)* 
                 acquired* 
 14 December 
     2020           100           42.9000          4,290.00 
 15 December 
     2020           100           42.4000          4,240.00 
 16 December 
     2020           100           42.0400          4,204.00 
 17 December 
     2020           100           41.8700          4,187.00 
   *Total*         *400*         *42.3025*        *16,921.00* 
 
The underlying individual trades are published on the website of QIAGEN N.V. 
(http://corporate.qiagen.om/investor-relations/share-information/share-buyba 
ck). 
 
The total number of shares which have already been bought back within the 
framework of such tranche of the share repurchase program from November 11, 
2020 until and including December 17, 2020 amounts to 1,345,901 shares. The 
average purchase price per share was EUR 39.48 a total price of EUR 
53,139,675.48 (excl. ancillary costs), which represents based on the ECB 
reference rate as of November 10, 2020 (EUR 1 = USD 1.1808) a USD amount of 
approximately 62.7 million was paid to buy back the shares. 
 
The purchase of the shares of QIAGEN N.V. was carried out by a financial 
institution that has been commissioned by QIAGEN N.V. 
 
Venlo, 22 December 2020 
 
Managing Board 
 
### 
*Contacts:* 
 
QIAGEN 
Investor Relations 
John Gilardi 
+49 2103 29 11711 
e-mail: ir@qiagen.com 
 
Public Relations 
Dr. Thomas Theuringer 
+49 2103 29 11826 
e-mail: pr@qiagen.com 
 
2020-12-22 The DGAP Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
Language: English 
Company:  QIAGEN N.V. 
          Hulsterweg 82 
          5912 PL Venlo 
          Netherlands 
Internet: www.qiagen.com 
 
End of News DGAP News Service 
 
1155273 2020-12-22

(END) Dow Jones Newswires

December 22, 2020 04:31 ET (09:31 GMT)